TheEdgeResearch
Home / Stocks / BHST

BioHarvest Sciences Inc. (BHST)

NASDAQ Industrials Agricultural - Commodities/Milling
$1.46 ▲ +0.69%
Market Cap
$25.3M
Sector
Industrials
Industry
Agricultural - Commodities/Milling
Beta
1.36
52-Wk Range
1.42-12.8
CEO
Zaki Rakib
Country
CA
Currency
USD

BioHarvest Sciences Inc. operates in the Agricultural - Commodities/Milling industry of the Industrials sector, headquartered in Vancouver, BC, CA. The stock last traded at $1.46, up 0.69% on the session, giving a market capitalisation of $25.3M. On trailing twelve-month figures it carries a trailing P/E of -2.70, a net margin of -31.2%. Its beta of 1.36 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-2.70
Price / Sales
0.71
Price / Book
1.67
EV / EBITDA
-3.65
Gross margin
59.0%
Operating margin
-18.0%
Net margin
-31.2%
Return on equity
—
Debt / equity
0.89
Current ratio
2.24
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
89
IPO date
2021-01-08
Headquarters
Vancouver, BC, CA
About BioHarvest Sciences Inc.

BioHarvest Sciences Inc. is a biotechnology company that operates through two segments: Products and CDMO Services. The company has developed a botanical synthesis platform technology to grow plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, and sale of science-based health and wellness nutraceutical solutions, as well as offering Contract Development and Manufacturing Operation (CDMO) services to third parties in the pharmaceutical, cosmeceutical, and nutrition industries.

Comparable companies

BioHarvest Sciences Inc. is most often compared with the following Industrials names:

ACNTAVDBIOXCMTFFFRDLVROMERCTRXUSGO
More research on BHST
BHST technical analysis BHST TheEdge Score Compare against peers
Open full interactive analysis & DCF →